AI 90-DAY FORECAST

BEARISH SIGNAL DETECTED · Alpha

██.█% Sign up free to reveal

Takeda Pharmaceutical Co Ltd (TAK) AI Forecast

Our AI ranks Takeda Pharmaceutical Co Ltd outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$TAK Bearish Signal Full forecast available

Takeda Pharmaceutical Co Ltd (TAK) Stock Forecast Sept. 24, 2026

Q: What factors influence Takeda Pharmaceutical Co Ltd stock price forecasts?

Our analysis considers financial metrics, sector trends, market sentiment, technical indicators, and macroeconomic factors.

Takeda Pharmaceutical Co Ltd (TAK) AI Stock Price Forecast & Investment Analysis

Latest Analysis Date: September 24, 2026

Loading chart...

Takeda Pharmaceutical Co Ltd (TAK) - Comprehensive Stock Analysis & Investment Research

Deep dive into Takeda Pharmaceutical Co Ltd's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 24, 2026 (UTC)

Takeda Pharmaceutical Co Ltd Investment Summary

When evaluating whether Takeda Pharmaceutical Co Ltd (TAK) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Takeda Pharmaceutical Co Ltd (TAK) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. . With a market capitalization of $30 billion, the company is a large-cap stock offering relative stability combined with growth potential.

Financial Performance Analysis

Our comprehensive financial analysis covers Takeda Pharmaceutical Co Ltd's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Takeda Pharmaceutical Co Ltd along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Takeda Pharmaceutical Co Ltd is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Takeda Pharmaceutical Co Ltd

Corporate Identity

Takeda Pharmaceutical Co Ltd (Stock Symbol: TAK) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Takeda Pharmaceutical Co Ltd's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Takeda Pharmaceutical Co Ltd...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Takeda Pharmaceutical Co Ltd...

Unlock Full Company Profile

Get complete details about Takeda Pharmaceutical Co Ltd

Revenue & Growth Analysis

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Takeda Pharmaceutical Co Ltd...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Takeda Pharmaceutical Co Ltd...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Takeda Pharmaceutical Co Ltd...

Unlock Financial Analysis

Get complete financial metrics for Takeda Pharmaceutical Co Ltd

AI ANALYSIS AVAILABLE

Unlock Takeda Pharmaceutical Co Ltd's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test

73.7% Rebalance periods with a positive net return

Daily Updates

Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Takeda Pharmaceutical Co Ltd strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.

Industry Competitive Landscape

Takeda Pharmaceutical Co Ltd competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

Financial Strength & Leverage

Takeda Pharmaceutical Co Ltd (TAK) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Takeda Pharmaceutical Co Ltd stock analysis. Financial statement data is not available for this company: its filings are not in a form the pipeline converts, so only market data is shown.

Deep dive into Takeda Pharmaceutical Co Ltd's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Takeda Pharmaceutical Co Ltd stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.